QVT Financial LP 13D and 13G filings for Roivant Sciences Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 2:00 pm Sale | 2024-12-31 | 13G | Roivant Sciences Ltd. ROIV | QVT Financial LP | 65,793,779 9.220% | -926,000 (-1.39%) | Filing |
| 2024-03-07 5:33 pm Sale | 2024-03-07 | 13G | Roivant Sciences Ltd. ROIV | QVT Financial LP | 66,719,779 8.280% | -45,821,757 (-40.72%) | Filing |
| 2024-02-14 11:14 am Sale | 2023-12-31 | 13G | Roivant Sciences Ltd. ROIV | QVT Financial LP | 112,541,536 13.970% | -10,000,000 (-8.16%) | Filing |
| 2023-02-14 11:46 am Sale | 2022-12-31 | 13G | Roivant Sciences Ltd. ROIV | QVT Financial LP | 122,541,536 16.890% | -6,852,281 (-5.30%) | Filing |
| 2022-02-14 3:00 pm Purchase | 2021-12-31 | 13G | Roivant Sciences Ltd. ROIV | QVT Financial LP | 129,393,817 18.700% | 129,393,817 (New Position) | Filing |